{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:05:47Z","timestamp":1758045947304,"version":"3.44.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"DOI":"10.7759\/cureus.92169","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:04:34Z","timestamp":1757711074000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Anticoagulant and Antiplatelet Therapy on the National Optimal Lung Cancer Pathway (NOLCP)"],"prefix":"10.7759","author":[{"given":"Alexandra","family":"Jagla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Daneshvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McDill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maged","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Lung cancer statistics. (2017). Accessed. 26\/06\/2025: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/lung-cancer."},{"key":"ref2","unstructured":"National lung cancer audit state of the nation 2025. (2025). Accessed. 26\/06\/2025: https:\/\/www.hqip.org.uk\/wp-content\/uploads\/2025\/04\/REF519_NLCA-SoN-v2.0_20250508-v2.pdf."},{"key":"ref3","unstructured":"Lung cancer. (2018). Accessed. 26\/06\/2025: https:\/\/www.abpi.org.uk\/facts-figures-and-industry-data\/cancer-in-the-uk-digital-data-toolkit\/lung-cancer\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00029-6","article-title":"Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial","volume":"3","author":"Navani N","year":"2015","unstructured":"Navani N, Nankivell M, Lawrence DR, et al.. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial. Lancet Respir Med. 2015, 3:282-9. 10.1016\/S2213-2600(15)00029-6","journal-title":"Lancet Respir Med"},{"key":"ref5","unstructured":"National optimal lung cancer pathway. for suspected and confirmed lung cancer: referral to treatment. (2020). Accessed: 26\/06\/2025: https:\/\/www.cancerresearchuk.org\/sites\/default\/files\/lung_cancer_implementation_guide_august_2017.pdf."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2019-0218","article-title":"Implementation and outcomes of the RAPID programme: addressing the front end of the lung cancer pathway in Manchester","volume":"20","author":"Evison M","year":"2020","unstructured":"Evison M, Hewitt K, Lyons J, et al.. Implementation and outcomes of the RAPID programme: addressing the front end of the lung cancer pathway in Manchester. Clin Med (Lond). 2020, 20:401-5. 10.7861\/clinmed.2019-0218","journal-title":"Clin Med (Lond)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08801-9","article-title":"The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study","volume":"21","author":"Niksic M","year":"2021","unstructured":"Niksic M, Redondo-Sanchez D, Chang YL, et al.. The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study. BMC Cancer. 2021, 21:1048. 10.1186\/s12885-021-08801-9","journal-title":"BMC Cancer"},{"key":"ref8","unstructured":"Heart statistics. (2020). Accessed. 26\/06\/2025: https:\/\/www.bhf.org.uk\/what-we-do\/our-research\/heart-statistics."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)60243-4","article-title":"Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments","author":"Mega JL","year":"2015","unstructured":"Mega JL, Simon T. Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments. Lancet. 2015, 18-24. 10.1016\/s0140-6736(15)60243-4","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-220304","article-title":"British Thoracic Society Guideline for pleural disease","volume":"78","author":"Roberts ME","year":"2023","unstructured":"Roberts ME, Rahman NM, Maskell NA, et al.. British Thoracic Society Guideline for pleural disease. Thorax. 2023, 78:10.1136\/thorax-2023-220304","journal-title":"Thorax"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.13342","article-title":"Management of anticoagulation and antiplatelet medications in adults undergoing percutaneous interventions","volume":"205","author":"Jaffe TA","year":"2015","unstructured":"Jaffe TA, Raiff D, Ho LM, Kim CY. Management of anticoagulation and antiplatelet medications in adults undergoing percutaneous interventions. AJR Am J Roentgenol. 2015, 205:421-8. 10.2214\/AJR.14.13342","journal-title":"AJR Am J Roentgenol"},{"key":"ref12","unstructured":"Millimetres matter. implementing the national optimal lung cancer pathway. (2018). Accessed: 26\/06\/2025: https:\/\/www.uklcc.org.uk\/sites\/default\/files\/2021-06\/UKLCC-Millimetres-Matter.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212588","article-title":"Impact of organisation and specialist service delivery on lung cancer outcomes","volume":"74","author":"Adizie JB","year":"2019","unstructured":"Adizie JB, Khakwani A, Beckett P, Hubbard R, Navani N, Harden SV, Woolhouse I. Impact of organisation and specialist service delivery on lung cancer outcomes. Thorax. 2019, 74:546-50. 10.1136\/thoraxjnl-2018-212588","journal-title":"Thorax"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/411118-impact-of-anticoagulant-and-antiplatelet-therapy-on-the-national-optimal-lung-cancer-pathway-nolcp","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:04:36Z","timestamp":1757711076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/411118-impact-of-anticoagulant-and-antiplatelet-therapy-on-the-national-optimal-lung-cancer-pathway-nolcp"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.92169","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]}}}